Combination therapy in hypertension: an Asia-Pacific consensus viewpoint

References

• World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. 2009. Available at: http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf [Last accessed 12 March 2013]
   Google Scholar
• Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159-219
   PubMed Web of Science ®Google Scholar
• Perkovic V, Huxley R, Wu Y, et al. The burden of blood pressure-related disease: a neglected priority for global health. Hypertension 2007;50:991-7
   PubMed Web of Science ®Google Scholar
• Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-23
   PubMed Web of Science ®Google Scholar
• Tomlinson B, Dalal JJ, Huang J, et al. The role of beta-blockers in the management of hypertension: an Asian perspective. Curr Med Res Opin 2011;27:1021-33
   PubMed Web of Science ®Google Scholar
• Xi B, Liang Y, Reilly KH, et al. Trends in prevalence, awareness, treatment, and control of hypertension among Chinese adults 1991–2009. Int J Cardiol 2012;158:326-9
   PubMed Web of Science ®Google Scholar
• Cheong AT, Tong SF, Sazlina SG, et al. Blood pressure control among hypertensive patients with and without diabetes mellitus in six public primary care clinics in Malaysia. Asia Pac J Public Health 2013: published online 27 March 2013, doi: 10.1177/1010539513480232
   Google Scholar
• Azarisman SM, Aszrin A, Marzuki AO, et al. Blood pressure control among diabetic hypertensives under cardiology follow-up at a regional hospital in rural Malaysia. Southeast Asian J Trop Med Public Health 2010;41:973-81
   PubMed Web of Science ®Google Scholar
• Cai L, Liu A, Zhang L, et al. Prevalence, awareness, treatment, and control of hypertension among adults in Beijing, China. Clin Exp Hypertens 2012;34:45-52
   PubMed Web of Science ®Google Scholar
• Jones DW, Kim JS, Kim SJ, Hong YP. Hypertension awareness, treatment and control rates for an Asian population: results from a national survey in Korea. Ethn Health 1996;1:269-73
   PubMedGoogle Scholar
• Katayama S, Inaba M, Morita T, et al. Blood pressure control in Japanese hypertensives with or without type 2 diabetes mellitus. Hypertens Res 2000;23:601-5
   PubMed Web of Science ®Google Scholar
• Chew BH, Mastura I, Shariff-Ghazali S, et al. Determinants of uncontrolled hypertension in adult type 2 diabetes mellitus: an analysis of the Malaysian diabetes registry 2009. Cardiovasc Diabetol 2012;11:54. doi: 10.1186/1475-2840-11-54
   PubMed Web of Science ®Google Scholar
• Ko SH, Kwon HS, Song KH, et al. Long-term changes of the prevalence and control rate of hypertension among Korean adults with diagnosed diabetes: 1998–2008 Korean National Health and Nutrition Examination Survey. Diabetes Res Clin Pract 2012;97:151-7
   PubMed Web of Science ®Google Scholar
• Wu Y, Tai ES, Heng D, et al. Risk factors associated with hypertension awareness, treatment, and control in a multi-ethnic Asian population. J Hypertens 2009;27:190-7
   PubMed Web of Science ®Google Scholar
• MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74
   PubMed Web of Science ®Google Scholar
• Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13
   PubMed Web of Science ®Google Scholar
• Dusing R. Optimizing blood pressure control through the use of fixed combinations. Vasc Health Risk Manag 2010;6:321-5
   PubMedGoogle Scholar
• Gradman AH, Basile JN, Carter BL, et al. Combination therapy in hypertension. J Am Soc Hypertens 2010;4:90-8
   PubMed Web of Science ®Google Scholar
• Struijker-Boudier HA, Ambrosioni E, Holzgreve H, et al. The need for combination antihypertensive therapy to reach target blood pressures: what has been learned from clinical practice and morbidity–mortality trials? Int J Clin Pract 2007;61:1592-602
   PubMed Web of Science ®Google Scholar
• Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 2003;326:1427
   PubMed Web of Science ®Google Scholar
• Wald DS, Law M, Morris JK, et al. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med 2009;122:290-300
   PubMed Web of Science ®Google Scholar
• Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension 2010;55:399-407
   PubMed Web of Science ®Google Scholar
• Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007;120:713-19
   PubMed Web of Science ®Google Scholar
• Gu Q, Burt VL, Dillon CF, Yoon S. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010. Circulation 2012;126:2105-14
   PubMed Web of Science ®Google Scholar
• Egan BM, Bandyopadhyay D, Shaftman SR, et al. Initial monotherapy and combination therapy and hypertension control the first year. Hypertension 2012;59:1124-31
   PubMed Web of Science ®Google Scholar
• Hess G, Hill J, Lau H, et al. Medication utilization patterns and hypertension-related expenditures among patients who were switched from fixed-dose to free-combination antihypertensive therapy. P & T : a peer-reviewed journal for formulary management 2008;33:652-66
   PubMedGoogle Scholar
• James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507-20
   PubMed Web of Science ®Google Scholar
• Williams B, Poulter NR, Brown MJ, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004;328:634-40
   PubMed Web of Science ®Google Scholar
• NICE. Hypertension – the clinical management of primary hypertension in adults. CG127. 2011. Available at: http://www.guidance.nice.org.uk/CG127 [Last accessed 13 March 2013]
   Google Scholar
• Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665
   PubMed Web of Science ®Google Scholar
• Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009;27:2121-58
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52
   PubMed Web of Science ®Google Scholar
• Cruickshank JM. Are we misunderstanding beta-blockers. Int J Cardiol 2007;120:10-27
   PubMed Web of Science ®Google Scholar
• Cruickshank JM. The Modern Role of Beta-Blockers in Cardiovascular Medicine. Shelton, USA: People’s Medical Publishing House, 2011
   Google Scholar
• Cruickshank JM. Essential Hypertension. Shelton, USA: People’s Medical Publishing House, 2013
   Google Scholar
• Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998;351:1755-62
   PubMed Web of Science ®Google Scholar
• Armed Forces Medical College. National Rural Health Mission (NRHM) Hypertension Standard Treatment Guidelines. Available at: http://www.nrhm.gov.in/images/pdf/guidelines/nrhm-guidelines/stg/hypertension.pdf. [Last accessed 13 March 2013]
   Google Scholar
• Association of Physicians of India. Indian Hypertension Guidelines II. The Association of Physicians in India. Available at: http://www.apiindia.org/pdf/hsi_guidelines_ii/managehypert.pdf [Last accessed 15 March 2013]
   Google Scholar
• Chiang CE, Wang TD, Li YH, et al. 2010 guidelines of the Taiwan Society of Cardiology for the management of hypertension. J Formos Med Assoc 2010;109:740-73
   PubMed Web of Science ®Google Scholar
• Liu LS, Writing Group of Chinese Guidelines for the Management of H. [2010 Chinese guidelines for the management of hypertension]. Zhonghua Xin Xue Guan Bing Za Zhi 2011;39:579-615
   PubMedGoogle Scholar
• Ministry of Health Malaysia. Clinical Practice Guidelines in Management of Hypertension (3rd Edition). 2008. Available at: http://www.moh.gov.my [Last accessed 15 March 2013]
   Google Scholar
• National Heart Foundation of Australia. Guide to management of hypertension 2008: assessing and managing raised blood pressure in adults. Updated December 2010. Availabe at: http://www.heartfoundation.org.au/Professional_Information/Clinical_Practice/Hypertension [Last accessed 13 March 2013]
   Google Scholar
• Abelardo NS, for the Multisectoral Task Force Consensus on the Detection and Management of Hypertension in the Philippines. Philippine Clinical Practice Guidelines on the Detection and Management of Hypertension – 2011. Available at: http://www.thefilipinodoctor.com/cpm_pdf/CPM15th%20HYPERTENSION%20%28PSH%29.pdf [Last accessed 10 September 2014]
   Google Scholar
• New Zealand Guidelines Group. New Zealand Primary Care Handbook 2012 (3rd Edition). 2012. Available at: http://www.health.govt.nz/publication/new-zealand-primary-care-handbook-2012 [Last accessed 14 March 2013]
   Google Scholar
• Ogihara T, Kikuchi K, Matsuoka H, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009;32:3-107
   PubMed Web of Science ®Google Scholar
• Park JB. 2004 Korean Hypertension Treatment Guideline and Its Perspective. Korean Circulation J 2006;36:405-10
   Google Scholar
• Singapore MoH. MOH Clinical Practice Guidelines: Hypertension 2/2005. 2005. Available at: http://www.moh.gov.sg/content/dam/moh_web/HPP/Doctors/cpg_medical/withdrawn/cpg_Hypertension-Jun%202005.pdf [Last accessed 12 June 2013]
   Google Scholar
• Thai Hypertension Society. Thai Guidelines on the Treatment of Hypertension Update 2012. Available at: http://www.thaihypertension.org/guideline.html [Last accessed 16 March 2013]
   Google Scholar
• Vietnamese Society of Hypertension, Vietnam Heart Association. Guidelines for Diagnosis, Treatment, Prevention of Hypertension 2014. Paper presented at: 1st Vietnam Congress of Hypertension, 17–18 May 2014, Hue City, Vietnam
   Google Scholar
• Perhimpunan Dokter Hipertensi Indonesia. Consensus Management of Hypertension 2014. [Konsensus penatalaksanaan hipertensi 2014]. Jakarta: Perhimpunan Dokter Hipertensi Indonesia (InaSH), 2014
   Google Scholar
• PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41
   PubMed Web of Science ®Google Scholar
• Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887-98
   PubMed Web of Science ®Google Scholar
• Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003
   PubMed Web of Science ®Google Scholar
• Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005;366:895-906
   PubMed Web of Science ®Google Scholar
• Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004;363:2022-31
   PubMed Web of Science ®Google Scholar
• Patel A, MacMahon S, Chalmers J, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007;370:829-40
   PubMed Web of Science ®Google Scholar
• Pepine CJ, Handberg EM, Cooper-DeHoff RM, et al. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil–Trandolapril Study (INVEST): a randomized controlled trial. JAMA 2003;290:2805-16
   PubMed Web of Science ®Google Scholar
• Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008;359:2417-28
   PubMed Web of Science ®Google Scholar
• Quan A. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev 2006;82:23-8
   PubMed Web of Science ®Google Scholar
• Tomlinson B. Pharmacokinetic and pharmacodynamic responses to cardiovascular drugs in Asians. Acta Pharmacological Sinica 1998;19:12-13
   Web of Science ®Google Scholar
• Burroughs VJ, Maxey RW, Levy RA. Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment. J Natl Med Assoc 2002;94:1-26
   PubMed Web of Science ®Google Scholar
• Rasool AH, Rahman AR, Ismail R, et al. Ethnic differences in response to non-selective beta-blockade among racial groups in Malaysia. Int J Clin Pharmacol Ther 2000;38:260-9
   PubMed Web of Science ®Google Scholar
• Sulaiman MN, Rahman AR, Noor AR. Effectiveness of combination therapy with or without diuretics in the treatment of essential hypertension. Asia Pac J Pharmacol 2001;15:17-24
   Google Scholar
• Brown MJ, Cruickshank JK, Dominiczak AF, et al. Better blood pressure control: how to combine drugs. J Hum Hypertens 2003;17:81-6
   PubMed Web of Science ®Google Scholar